Marta Lavrador
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marta Lavrador has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Isabel Vitória Figueiredo
University of Coimbra
13 shared publications - Margarida Castel-Branco
University of Coimbra
12 shared publications - Ana C. Cabral
University of Coimbra
10 shared publications - Fernando Fernandez-Llimos
University of Porto
10 shared publications - Manuel Teixeira Veríssimo
Faculty of Medicine, University of Coimbra, Coimbra, Portugal
3 shared publications - Joelizy Oliveira
Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
2 shared publications
Latest Publications
- 9 November 2026
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- p. 1-16
Current and emerging measures and methods for evaluating medication adherence behaviors
Medication adherence is a key determinant of treatment effectiveness and health outcomes, yet it remains a major challenge in clinical practice and research. As dynamic and multidimensional behavior influenced by cognitive, emotional, and contextual factors, adherence cannot be fully captured by a single measure. This complexity is further amplified in real-world settings characterized by multimorbidity and polypharmacy. This review examines current and emerging methods for measuring medication adherence. It considers the data sources and computation procedures required. These methods were classified into self-report instruments, electronic monitoring systems, administrative pharmacy claims, and group-based trajectory modeling. It discusses their conceptual basis, strengths, and limitations, highlighting how different methods capture distinct dimensions of adherence behavior. No single method represents a universal gold standard, and adherence measures are not interchangeable. Selection should be guided by the research objective, whether focused on exposure, determinants, or outcomes. Future advances will depend on integrating complementary methods and adopting longitudinal approaches to better reflect the dynamic nature of adherence and support more effective interventions.
- 9 November 2026
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- p. 1-16
Current and emerging measures and methods for evaluating medication adherence behaviors
Medication adherence is a key determinant of treatment effectiveness and health outcomes, yet it remains a major challenge in clinical practice and research. As dynamic and multidimensional behavior influenced by cognitive, emotional, and contextual factors, adherence cannot be fully captured by a single measure. This complexity is further amplified in real-world settings characterized by multimorbidity and polypharmacy. This review examines current and emerging methods for measuring medication adherence. It considers the data sources and computation procedures required. These methods were classified into self-report instruments, electronic monitoring systems, administrative pharmacy claims, and group-based trajectory modeling. It discusses their conceptual basis, strengths, and limitations, highlighting how different methods capture distinct dimensions of adherence behavior. No single method represents a universal gold standard, and adherence measures are not interchangeable. Selection should be guided by the research objective, whether focused on exposure, determinants, or outcomes. Future advances will depend on integrating complementary methods and adopting longitudinal approaches to better reflect the dynamic nature of adherence and support more effective interventions.
- Open Access
- 26 October 2026
- Published by Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC) in Farmacéuticos Comunitarios
- Vol. 19 (1)
Addressing medication complexity in outpatient care: are Multicompartment Compliance Aids enough?
Introduction: Medication regimen complexity contributes to unintentional non-adherence, particularly in older adults and patients with chronic conditions. Multicompartment compliance aids (MCAs) are widely used to support adherence, but their real-world effectiveness in outpatients with high regimen complexity remains uncertain. Aim: To evaluate the suitability of MCAs in outpatients with high medication regimen complexity using the Medication Regimen Complexity Index (MRCI). Method: A cross-sectional study was conducted in five community pharmacies in Central Portugal (January–July 2023). Adults (>18 years), autonomous in medication management, were included. Medication data were collected through semi-structured interviews and analyzed using the MRCI. Each medicine was assessed for MCA suitability according to national and international guidelines. Associations between MRCI and MCA feasibility were analyzed using appropriate statistical tests (p < 0.05). Results: Among 189 participants (64.6% female; median age 72 years), 94.7% were under polypharmacy and 23.8% under hyper-polypharmacy. The median number of medications was 7, and the median MRCI score was 26, with 51.9% at or above this threshold. MRCI strongly correlated with medication number (ρ = 0.918; p < 0.001). Although 79.4% of regimens were eligible for MCA inclusion, only 42.7% of eligible regimens were fully accommodated. Patients with lower MRCI scores had a 3.8-fold higher likelihood of full MCA inclusion (72.7% vs. 19.1%; χ² = 43.5; p < 0.001). Conclusion: MCAs alone may be insufficient for patients with high regimen complexity. Combining MCA use with structured medication reviews and regimen simplification may improve adherence.
- 26 October 2026
- Published by Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC) in Farmacéuticos Comunitarios
- Vol. 19 (1)
Open AccessAddressing medication complexity in outpatient care: are Multicompartment Compliance Aids enough?
Introduction: Medication regimen complexity contributes to unintentional non-adherence, particularly in older adults and patients with chronic conditions. Multicompartment compliance aids (MCAs) are widely used to support adherence, but their real-world effectiveness in outpatients with high regimen complexity remains uncertain. Aim: To evaluate the suitability of MCAs in outpatients with high medication regimen complexity using the Medication Regimen Complexity Index (MRCI). Method: A cross-sectional study was conducted in five community pharmacies in Central Portugal (January–July 2023). Adults (>18 years), autonomous in medication management, were included. Medication data were collected through semi-structured interviews and analyzed using the MRCI. Each medicine was assessed for MCA suitability according to national and international guidelines. Associations between MRCI and MCA feasibility were analyzed using appropriate statistical tests (p < 0.05). Results: Among 189 participants (64.6% female; median age 72 years), 94.7% were under polypharmacy and 23.8% under hyper-polypharmacy. The median number of medications was 7, and the median MRCI score was 26, with 51.9% at or above this threshold. MRCI strongly correlated with medication number (ρ = 0.918; p < 0.001). Although 79.4% of regimens were eligible for MCA inclusion, only 42.7% of eligible regimens were fully accommodated. Patients with lower MRCI scores had a 3.8-fold higher likelihood of full MCA inclusion (72.7% vs. 19.1%; χ² = 43.5; p < 0.001). Conclusion: MCAs alone may be insufficient for patients with high regimen complexity. Combining MCA use with structured medication reviews and regimen simplification may improve adherence.
- Open Access
- 15 October 2025
- Published by Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC) in Farmacéuticos Comunitarios
- Vol. 17 (4) , 23-29
Servicio de revisión del uso de medicamentos en farmacias comunitarias: una puerta abierta a otros servicios farmacéuticos clínicos
Realizar un servicio de revisión del uso de medicamentos (RUM) y aplicar una metodología para adaptar a los pacientes a servicios clínicos más complejos dirigidos por farmacéuticos. Se realizó una consulta RUM para la revisión con el paciente de todos los medicamentos para asegurar que los medicamentos se están tomando correctamente con participantes de cinco farmacias comunitarias. El ‘Cuestionario universal de adherencia a la medicación’ (MAUQ) y el ‘Cuestionario de creencias sobre los medicamentos’ (BMQ) se añadieron al protocolo. El Índice de complejidad del régimen de medicación (MRCI) se calculó para pacientes no adherentes no intencionales. Luego, se aplicó un algoritmo de derivación para servicios clínicos más complejos dirigidos por farmacéuticos, como la revisión de la medicación, la preparación de sistemas personalizados de reacondicionamiento (SPD) o la educación del paciente, para adaptar un plan a cada participante. De los 189 pacientes incluidos, 100 (52,9 %) fueron derivados a un servicio de revisión de la medicación porque usaban al menos un medicamento de alto riesgo, presentaban quejas clínicamente significativas y/o usaban al menos 10 medicamentos. Del resto, el MAUQ mostró un 46,1 % de no adherentes y el BMQ reveló un 26,8 % de no adherentes intencionales, lo que indica la necesidad de servicios de educación/alfabetización en salud. Dentro del 73,2 % de no adherentes no intencionales, el 46,7 % presentó un MRCI por debajo del valor medio, beneficiándose de estrategias de memoria o derivación a la preparación de SPD, mientras que el 53,3 % necesitó una revisión de la medicación. El RUM resolvió los problemas de uso de medicamentos para 48 pacientes y potencialmente benefició a otros 25. Conclusiones: el RUM, combinado con la evaluación de la adherencia a la medicación y la posterior aplicación de un algoritmo de derivación, identificó a los pacientes con diferentes perfiles de necesidades, actuando como una puerta abierta a servicios más complejos dirigidos por farmacéuticos que mejor atienden las necesidades de los pacientes en una farmacia comunitaria.
- 15 October 2025
- Published by Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC) in Farmacéuticos Comunitarios
- Vol. 17 (4) , 23-29
Open AccessServicio de revisión del uso de medicamentos en farmacias comunitarias: una puerta abierta a otros servicios farmacéuticos clínicos
Realizar un servicio de revisión del uso de medicamentos (RUM) y aplicar una metodología para adaptar a los pacientes a servicios clínicos más complejos dirigidos por farmacéuticos. Se realizó una consulta RUM para la revisión con el paciente de todos los medicamentos para asegurar que los medicamentos se están tomando correctamente con participantes de cinco farmacias comunitarias. El ‘Cuestionario universal de adherencia a la medicación’ (MAUQ) y el ‘Cuestionario de creencias sobre los medicamentos’ (BMQ) se añadieron al protocolo. El Índice de complejidad del régimen de medicación (MRCI) se calculó para pacientes no adherentes no intencionales. Luego, se aplicó un algoritmo de derivación para servicios clínicos más complejos dirigidos por farmacéuticos, como la revisión de la medicación, la preparación de sistemas personalizados de reacondicionamiento (SPD) o la educación del paciente, para adaptar un plan a cada participante. De los 189 pacientes incluidos, 100 (52,9 %) fueron derivados a un servicio de revisión de la medicación porque usaban al menos un medicamento de alto riesgo, presentaban quejas clínicamente significativas y/o usaban al menos 10 medicamentos. Del resto, el MAUQ mostró un 46,1 % de no adherentes y el BMQ reveló un 26,8 % de no adherentes intencionales, lo que indica la necesidad de servicios de educación/alfabetización en salud. Dentro del 73,2 % de no adherentes no intencionales, el 46,7 % presentó un MRCI por debajo del valor medio, beneficiándose de estrategias de memoria o derivación a la preparación de SPD, mientras que el 53,3 % necesitó una revisión de la medicación. El RUM resolvió los problemas de uso de medicamentos para 48 pacientes y potencialmente benefició a otros 25. Conclusiones: el RUM, combinado con la evaluación de la adherencia a la medicación y la posterior aplicación de un algoritmo de derivación, identificó a los pacientes con diferentes perfiles de necesidades, actuando como una puerta abierta a servicios más complejos dirigidos por farmacéuticos que mejor atienden las necesidades de los pacientes en una farmacia comunitaria.
- Open Access
- 18 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6584
Drug-Induced Hyponatremia: Insights into Pharmacological Mechanisms and Clinical Practice Management
Background: Hyponatremia (serum sodium concentration < 135 mmol/L) represents the most common electrolyte disturbance in clinical practice, particularly among high-risk populations such as older adults. Its severity ranges from moderately severe to life-threatening symptoms, contributing to increased mortality. Its etiology is widely heterogeneous and leads to different classifications according to volume status such as hypovolemic, euvolemic and hypervolemic hyponatremia. Drug-induced hyponatremia presents itself as one of the most prevalent but frequently overlooked causes, since many confounding factors like associated comorbidities and polypharmacy complicate the identification of specific medicines as the main offenders. Objectives: This narrative review was performed to provide a comprehensive analysis on drug-induced hyponatremia, focusing not only on the underlying pharmacological mechanisms, but also on management strategies in clinical practice. Methods: A narrative literature review was conducted using PubMed, Science Direct and Google Scholar. Results: This narrative review focused not only on the most common drug classes to induce hyponatremia through different mechanisms, including diuretics, antidepressants, anticonvulsants, and antipsychotics, but also on other pharmacological classes, that, although to a lesser extent, might also be associated with decreasing serum sodium levels (antineoplastic and immunomodulating agents, drugs acting on digestive and locomotor systems, anti-infective drugs, endocrine diseases drugs, among others). It also explores recommendations on the management of drug-induced hyponatremia and it emphasizes the role of healthcare providers in addressing this electrolyte disorder. Conclusions: As drug-induced hyponatremia poses significant challenges in clinical practice, understanding its mechanisms, coupled with effective management strategies, can enhance patient safety.
- 18 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6584
Open AccessDrug-Induced Hyponatremia: Insights into Pharmacological Mechanisms and Clinical Practice Management
Background: Hyponatremia (serum sodium concentration < 135 mmol/L) represents the most common electrolyte disturbance in clinical practice, particularly among high-risk populations such as older adults. Its severity ranges from moderately severe to life-threatening symptoms, contributing to increased mortality. Its etiology is widely heterogeneous and leads to different classifications according to volume status such as hypovolemic, euvolemic and hypervolemic hyponatremia. Drug-induced hyponatremia presents itself as one of the most prevalent but frequently overlooked causes, since many confounding factors like associated comorbidities and polypharmacy complicate the identification of specific medicines as the main offenders. Objectives: This narrative review was performed to provide a comprehensive analysis on drug-induced hyponatremia, focusing not only on the underlying pharmacological mechanisms, but also on management strategies in clinical practice. Methods: A narrative literature review was conducted using PubMed, Science Direct and Google Scholar. Results: This narrative review focused not only on the most common drug classes to induce hyponatremia through different mechanisms, including diuretics, antidepressants, anticonvulsants, and antipsychotics, but also on other pharmacological classes, that, although to a lesser extent, might also be associated with decreasing serum sodium levels (antineoplastic and immunomodulating agents, drugs acting on digestive and locomotor systems, anti-infective drugs, endocrine diseases drugs, among others). It also explores recommendations on the management of drug-induced hyponatremia and it emphasizes the role of healthcare providers in addressing this electrolyte disorder. Conclusions: As drug-induced hyponatremia poses significant challenges in clinical practice, understanding its mechanisms, coupled with effective management strategies, can enhance patient safety.
- Open Access
- 27 August 2024
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 46 (5) , 1243
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ
- 27 August 2024
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 46 (5) , 1243
Open AccessCorrection: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ
- Open Access
- 27 December 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 46 (2) , 411-420
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study
Background: Patients often require adjustments to drug doses due to impaired renal function. Glomerular filtration rate (GFR) estimation using various equations can result in discrepancies, potentially leading to different dose adjustment recommendations. Aim: To determine the clinical significance of discrepancies observed between different equations used to estimate GFR for drug dose adjustments in a real-world group of patients over 65 years in primary care. Method: The Cockcroft–Gault (CG), Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Berlin Initiative Study 1 equations were applied to estimate GFR in a group of patients over 65 years old attending a primary care center. Results were compared using Bland–Altman plots, and limits of agreement (LoA) and overall bias were calculated. Regression analyses were conducted to identify the null difference GFR and the slope of differences for each pairwise comparison. Results: A total of 1886 patients were analyzed. Differences between patient-adjusted and body surface area (BSA)-normalized versions of the equations were not clinically relevant for dose adjustments, with LoAs below 20 mL/min. However, discrepancies among the original versions of several equations presented LoAs over 30 mL/min. Greater differences were found between CG and MDRD or CKD-EPI equations. Conclusion: Clinically relevant differences in GFR estimation were observed among different equations, potentially impacting drug dose adjustments. However, discrepancies were not considered significant when comparing patient-adjusted and BSA-normalized versions of the equations, particularly for patients with BSA close to the average.
- 27 December 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 46 (2) , 411-420
Open AccessDiscrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study
Background: Patients often require adjustments to drug doses due to impaired renal function. Glomerular filtration rate (GFR) estimation using various equations can result in discrepancies, potentially leading to different dose adjustment recommendations. Aim: To determine the clinical significance of discrepancies observed between different equations used to estimate GFR for drug dose adjustments in a real-world group of patients over 65 years in primary care. Method: The Cockcroft–Gault (CG), Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Berlin Initiative Study 1 equations were applied to estimate GFR in a group of patients over 65 years old attending a primary care center. Results were compared using Bland–Altman plots, and limits of agreement (LoA) and overall bias were calculated. Regression analyses were conducted to identify the null difference GFR and the slope of differences for each pairwise comparison. Results: A total of 1886 patients were analyzed. Differences between patient-adjusted and body surface area (BSA)-normalized versions of the equations were not clinically relevant for dose adjustments, with LoAs below 20 mL/min. However, discrepancies among the original versions of several equations presented LoAs over 30 mL/min. Greater differences were found between CG and MDRD or CKD-EPI equations. Conclusion: Clinically relevant differences in GFR estimation were observed among different equations, potentially impacting drug dose adjustments. However, discrepancies were not considered significant when comparing patient-adjusted and BSA-normalized versions of the equations, particularly for patients with BSA close to the average.
- Open Access
- 17 June 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (4) , 999-1006
Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ
Background: Different questionnaires assess self-reported medication adherence and others quantify aspects of patients attitudes towards medication, but not together in a single instrument. Gathering these two aspects in a single instrument could reduce patients survey burden. Aim: The aim of this study was to develop the Medication Adherence Universal Questionnaire (MAUQ) using the Maastricht Utrecht Adherence in Hypertension short version (MUAH-16) factorial structure as the hypothesized model. Method: A multistep process started with the modification of the MUAH-16 to obtain the MAUQ. Patients using at least one antihypertensive medicine were recruited. The two questionnaires, the MUAH-16 and MAUQ, were applied. A confirmatory factor analysis (CFA) was performed using the initial MUAH-16 s-order 4-factor model. An additional bifactor model with four uncorrelated factors and an overall score was tested. The comparative fit index (CFI), root mean square error of approximation (RMSEA) with confidence intervals (CIs), and standardized root mean squared residual (SRMR) were used to assess both models. Results: A sample of 300 hypertensive patients completed the instruments. The CFA with the second-order 4-factor solution resulted in similar results for the MUAH-16 and MAUQ: CFIs of 0.934 and 0.930, RMSEAs of 0.043 [CI 0.030–0.056] and 0.045 [CI 0.031–0.057] and SRMRs of 0.060 and 0.061, respectively. The CFA with the bifactor model showed slightly better results for both the MUAH-16 and MAUQ: CFIs of 0.974 and 0.976, RMSEAs of 0.030 [CI 0.005–0.046] and 0.028 [CI 0.001–0.044], and SRMRs of 0.043 and 0.044, respectively. Conclusion: CFA demonstrated that the MAUQ presented a better fit to both models than the MUAH-16, obtaining a robust universal free instrument to assess medicine-taking behaviour and four medicine beliefs components.
- 17 June 2023
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 45 (4) , 999-1006
Open AccessDevelopment and validation of a Medication Adherence Universal Questionnaire: the MAUQ
Background: Different questionnaires assess self-reported medication adherence and others quantify aspects of patients attitudes towards medication, but not together in a single instrument. Gathering these two aspects in a single instrument could reduce patients survey burden. Aim: The aim of this study was to develop the Medication Adherence Universal Questionnaire (MAUQ) using the Maastricht Utrecht Adherence in Hypertension short version (MUAH-16) factorial structure as the hypothesized model. Method: A multistep process started with the modification of the MUAH-16 to obtain the MAUQ. Patients using at least one antihypertensive medicine were recruited. The two questionnaires, the MUAH-16 and MAUQ, were applied. A confirmatory factor analysis (CFA) was performed using the initial MUAH-16 s-order 4-factor model. An additional bifactor model with four uncorrelated factors and an overall score was tested. The comparative fit index (CFI), root mean square error of approximation (RMSEA) with confidence intervals (CIs), and standardized root mean squared residual (SRMR) were used to assess both models. Results: A sample of 300 hypertensive patients completed the instruments. The CFA with the second-order 4-factor solution resulted in similar results for the MUAH-16 and MAUQ: CFIs of 0.934 and 0.930, RMSEAs of 0.043 [CI 0.030–0.056] and 0.045 [CI 0.031–0.057] and SRMRs of 0.060 and 0.061, respectively. The CFA with the bifactor model showed slightly better results for both the MUAH-16 and MAUQ: CFIs of 0.974 and 0.976, RMSEAs of 0.030 [CI 0.005–0.046] and 0.028 [CI 0.001–0.044], and SRMRs of 0.043 and 0.044, respectively. Conclusion: CFA demonstrated that the MAUQ presented a better fit to both models than the MUAH-16, obtaining a robust universal free instrument to assess medicine-taking behaviour and four medicine beliefs components.
- Open Access
- 14 March 2022
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 20 (2) , 01-08
Pharmacist-led medication reconciliation on admission to an acute psychiatric hospital unit
Background: Therapy management in patients suffering from mental health disorders is complex and the risks derived from changes or interruptions of treatment should not be ignored. Medication reconciliation in psychiatry may reduce medication errors and promote patient safety during transitions of care. Objective: To identify the influence of complementary information sources in the construction of the best possible medication history, and to ascertain the potential clinical impact of discrepancies identified in a medication reconciliation service. Methods: An observational study was conducted in an acute mental hospital unit, with a further validation in an internal medicine unit. Adult patients taking at least one medicine admitted in the unit were included. Patients/caregivers were interviewed upon admission and the information gathered was compared with hospital medical and shared electronic medical records. Once the best possible medication history was gathered, therapeutic information was reconciled against the prescription on admission to identify discrepancies. Potential clinical impact of medication errors was classified using the International Safety Classification. Results: During the study period, 148 patients were admitted, 50.7% females, mean age 54.6 years (SD=16.3). Collaboration of a caregiver was a needed in 74% of the interviews. In total, 1,147 drugs were considered to obtain patients’ best possible medication history. After reconciliation, 560 clinically sound intentional discrepancies were identified and 359 discrepancies required further clarification from prescribers: 84.12% “drug omission”, 5.57% “drug substitution”, 6.96% “dose change”, and 3.34% “dosage frequency change”. Potential clinical impact of these medication discrepancies was classified as: 95 mild, 100 moderate, and 29 severe medication errors. Conclusion: About 1 in three intentional discrepancies observed in a pharmacists-led medication reconciliation service required further clarification from prescribers, being 80% of them unintentional discrepancies. Results highlight the importance of the caregiver as source of information for the psychiatric patient, the relevance of analyzing shared electronic health records until 6 months before, and the need to use hospital medical records efficiently. Additionally, 29 discrepancies were classified as errors with potentially severe clinical impact. A medication reconciliation service is concluded to be feasible and necessary in a mental health unit. Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 14 March 2022
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 20 (2) , 01-08
Open AccessPharmacist-led medication reconciliation on admission to an acute psychiatric hospital unit
Background: Therapy management in patients suffering from mental health disorders is complex and the risks derived from changes or interruptions of treatment should not be ignored. Medication reconciliation in psychiatry may reduce medication errors and promote patient safety during transitions of care. Objective: To identify the influence of complementary information sources in the construction of the best possible medication history, and to ascertain the potential clinical impact of discrepancies identified in a medication reconciliation service. Methods: An observational study was conducted in an acute mental hospital unit, with a further validation in an internal medicine unit. Adult patients taking at least one medicine admitted in the unit were included. Patients/caregivers were interviewed upon admission and the information gathered was compared with hospital medical and shared electronic medical records. Once the best possible medication history was gathered, therapeutic information was reconciled against the prescription on admission to identify discrepancies. Potential clinical impact of medication errors was classified using the International Safety Classification. Results: During the study period, 148 patients were admitted, 50.7% females, mean age 54.6 years (SD=16.3). Collaboration of a caregiver was a needed in 74% of the interviews. In total, 1,147 drugs were considered to obtain patients’ best possible medication history. After reconciliation, 560 clinically sound intentional discrepancies were identified and 359 discrepancies required further clarification from prescribers: 84.12% “drug omission”, 5.57% “drug substitution”, 6.96% “dose change”, and 3.34% “dosage frequency change”. Potential clinical impact of these medication discrepancies was classified as: 95 mild, 100 moderate, and 29 severe medication errors. Conclusion: About 1 in three intentional discrepancies observed in a pharmacists-led medication reconciliation service required further clarification from prescribers, being 80% of them unintentional discrepancies. Results highlight the importance of the caregiver as source of information for the psychiatric patient, the relevance of analyzing shared electronic health records until 6 months before, and the need to use hospital medical records efficiently. Additionally, 29 discrepancies were classified as errors with potentially severe clinical impact. A medication reconciliation service is concluded to be feasible and necessary in a mental health unit. Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- Open Access
- 4 March 2022
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 35 (11) , 798-806
Reconciliação Terapêutica na Admissão de um Serviço de Medicina Interna: Estudo-Piloto
Introdução: A reconciliação terapêutica visa promover a segurança do doente por meio da redução de erros de medicação e eventos adversos decorrentes de discrepâncias de medicação na transição de cuidados. Foi nosso objetivo realizar um estudo-piloto de reconciliação terapêutica no momento da admissão hospitalar para, a partir dele, identificarmos os recursos necessários para a sua implementação na prática clínica.Material e Métodos: Estudo-piloto com 100 doentes admitidos num serviço de Medicina Interna entre outubro e dezembro de 2019, com mais de 18 anos e a tomar cronicamente pelo menos um medicamento. A melhor história farmacoterapêutica possível foi obtida sistematicamente, com posterior identificação, classificação e resolução das discrepâncias.Resultados: A amostra em estudo, em geral polimedicada e com múltiplas morbilidades, apresentou uma média de idades de 77,04 ± 13,74 anos, sendo 67,0% do sexo masculino. Foram identificadas 791 discrepâncias e as intencionais (95,7%) estavam documentadas em 50,9% das situações. As dificuldades encontradas relacionaram-se principalmente com o acesso e a qualidade da informação terapêutica e com a dificuldade de comunicação entre os diversos profissionais de saúde. Os principais recursos prioritários identificados relacionaram-se com as categorias de processo, ferramentas e pessoal.Conclusão: Os dados revelaram fragilidades nos registos clínicos disponíveis na interface dos cuidados primários/hospitalares. A otimização das fontes de dados, normalização e informatização do processo, atuação multidisciplinar e definição de grupos prioritários foram identificadas como oportunidades de otimização.
- 4 March 2022
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 35 (11) , 798-806
Open AccessReconciliação Terapêutica na Admissão de um Serviço de Medicina Interna: Estudo-Piloto
Introdução: A reconciliação terapêutica visa promover a segurança do doente por meio da redução de erros de medicação e eventos adversos decorrentes de discrepâncias de medicação na transição de cuidados. Foi nosso objetivo realizar um estudo-piloto de reconciliação terapêutica no momento da admissão hospitalar para, a partir dele, identificarmos os recursos necessários para a sua implementação na prática clínica.Material e Métodos: Estudo-piloto com 100 doentes admitidos num serviço de Medicina Interna entre outubro e dezembro de 2019, com mais de 18 anos e a tomar cronicamente pelo menos um medicamento. A melhor história farmacoterapêutica possível foi obtida sistematicamente, com posterior identificação, classificação e resolução das discrepâncias.Resultados: A amostra em estudo, em geral polimedicada e com múltiplas morbilidades, apresentou uma média de idades de 77,04 ± 13,74 anos, sendo 67,0% do sexo masculino. Foram identificadas 791 discrepâncias e as intencionais (95,7%) estavam documentadas em 50,9% das situações. As dificuldades encontradas relacionaram-se principalmente com o acesso e a qualidade da informação terapêutica e com a dificuldade de comunicação entre os diversos profissionais de saúde. Os principais recursos prioritários identificados relacionaram-se com as categorias de processo, ferramentas e pessoal.Conclusão: Os dados revelaram fragilidades nos registos clínicos disponíveis na interface dos cuidados primários/hospitalares. A otimização das fontes de dados, normalização e informatização do processo, atuação multidisciplinar e definição de grupos prioritários foram identificadas como oportunidades de otimização.